Table 2 Determinants of death with functioning graft in univariate analyses

RI categories (ref = RI < 0.70 both at 1 month & 3 months)

1

RI < 0.70 at 1 month & RI ≥ 0.70 at 3 months

2.15 [1.29–3.60]

RI ≥ 0.70 at 1 month & RI < 0.70 at 3 months

1.90 [1.20–3.03]

RI ≥ 0.70 at 1 month & RI ≥ 0.70 at 3 months

3.77 [2.71–5.24]

 Cardiovascular death

1.59 [1.16–2.16]

 Donor with diabetes

1.07 [0.54–2.11]

 Donor gender (Male)

1.01 [0.77–1.33]

 Donor Age (per 10 year increase)

1.30 [1.20–1.42]

 Donor Age > 60

1.85 [1.44–2.39]

 Cold ischemia (per 1 h increase)

1.01 [0.99–1.02]

 Diabetes

3.44 [2.52–4.70]

 NODAT

0.75 [0.66–1.35]

 Hemodialysis time > 1 year

1.38 [0.98–1.92]

 Hemodialysis time (per 1 year increase)

1.02 [0.99–1.06]

 Age (per 10 year increase)

1.92 [1.71–2.16]

 Age > 60 years

3.70 [2.85–4.80]

 Male gender

1.25 [0.95–1.65]

 BMI > 25

1.68 [1.28–2.20]

 BMI (per 5 pt. increase)

1.35 [1.18–1.54]

 1990–1999

0.98 [0.59–1.64]

 2000–2009

1.03 [0.64–1.66]

 2010–2017

1.42 [0.85–2.40]

 Double transplantation

2.86 [1.11–7.40]

 Perfusion machine

2.49 [1.50–4.15]

 DGF

1.38 [1.01–1.89]

 SBP > 140 mmHg

1.67 [1.27–2.18]

 SBP (per 10 mmHg increase)

1.15 [1.07–1.23]

 DBP > 90 mmHg

0.47 [0.24–0.91]

 PB (per 10 mmHg increase)

0.87 [0.77–0.98]

 PP > 50 mmHg

2.12 [1.54–2.91]

 PP (per 10 mmHg increase)

1.25 [1.25–1.35]

 eGFR < 45 ml/min

1.39 [1.06–1.82]

 eGFR MDRD (per 10 ml/min/1.73 m2 increase)

0.89 [0.82–0.96]

 Tacrolimus

1.18 [0.89–1.57]

 IL2-R antibodies

1.18 [0.89–1.57]

 RIM1 (per 0.1 increase)

1.93 [1.65–2.24]

 RIM3 (per 0.1 increase)

2.27 [1.91–2.69]